Pedro C. Da Silva

Santa Maria, PT 
Santa Maria, PT 

Overview

Pedro Da Silva practices practicing medicine in Santa Maria, Portugal.

His clinical expertise encompasses Heart Attack, Heart Failure, Coronary Heart Disease, Thrombectomy, and Percutaneous Coronary Intervention (PCI).

He is actively involved in clinical research, co-authoring 13 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Santa Maria, Portugal
Other Locations
Lisbon, Portugal

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Practical Evaluation of Fractional Flow Reserve (FFR) and Its Associated Alternate Indices During Routine Clinical Procedures
Practical Evaluation of Fractional Flow Reserve (FFR) and Its Associated Alternate Indices During Routine Clinical Procedures
Enrollment Status: Completed
Publish Date: February 07, 2020
Intervention Type: Device
Prospective, Single Arm, Multi-centre, Observational Registry to Further Validate Safety and Efficacy of the Ultimaster Des System in Unselected Patients Representing Everyday Clinical Practice
Prospective, Single Arm, Multi-centre, Observational Registry to Further Validate Safety and Efficacy of the Ultimaster Des System in Unselected Patients Representing Everyday Clinical Practice
Enrollment Status: Unknown
Publish Date: October 08, 2019
View 1 Less Clinical Trial

13 Total Publications

The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS Trial.
The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS Trial.
Journal: Clinical research in cardiology : official journal of the German Cardiac Society
Published: December 03, 2019

Frequently Asked Questions about Pedro C. Da Silva

Is Pedro C. Da Silva a top-rated expert for Heart Attack?

MediFind is an objective health platform that identifies experts based on real-world data. Pedro C. Da Silva is classified as an Experienced expert for Heart Attack, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Pedro C. Da Silva participate in research or clinical trials?

Yes. Pedro C. Da Silva has published 13 articles and abstracts on conditions like Heart Attack. You can view a list of Pedro C. Da Silva's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Da Silva's expertise for a condition
ConditionClose
        View All 13 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile